UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article

Biomedicines, 2020-07, Vol.8 (7), p.227

2020

Volltextzugriff (PDF)

Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)

Medicina (Kaunas, Lithuania), 2024-04, Vol.60 (4), p.659

2024

Volltextzugriff (PDF)

Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study

BMJ neurology open, 2021-07, Vol.3 (2), p.e000108-e000108

2021

Volltextzugriff (PDF)

Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry

BMC neurology, 2020-12, Vol.20 (1), p.439-439, Article 439

2020

Volltextzugriff (PDF)

Clinical Trial Awareness in the Black Population from the National African Americans with Multiple Sclerosis Registry (P5-4.007)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE)

Multiple sclerosis, 2023-07, Vol.29 (8), p.956-966

2023

Volltextzugriff (PDF)

Evaluating decision regret after extremely preterm birth

Archives of disease in childhood. Fetal and neonatal edition, 2024-08, p.fetalneonatal-2024-327287

2024

Volltextzugriff (PDF)

Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis

Multiple sclerosis and related disorders, 2024-10, Vol.90, p.105799, Article 105799

2024

Volltextzugriff (PDF)

Advancing Care and Outcomes for African American Patients With Multiple Sclerosis

Neurology, 2022-06, Vol.98 (24), p.1015-1020

2022

Volltextzugriff (PDF)

National African American Multiple Sclerosis Registry: Advancing Equitable Care and Outcomes for African Americans with Multiple Sclerosis (4957)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

N-Terminomics identifies HtrA1 cleavage of thrombospondin-1 with generation of a proangiogenic fragment in the polarized retinal pigment epithelial cell model of age-related macular degeneration

Matrix biology, 2018-09, Vol.70, p.84-101

2018

Volltextzugriff (PDF)

Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab (OCTAVE) (P3.2-056)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center

Multiple sclerosis, 2018-06, Vol.24 (7), p.942-950

2018

Volltextzugriff (PDF)

Comparing Quality of Life Between People Who Use Injectable Disease-Modifying Therapies and Those Who Switch to Oral Therapies: A Study From the Pacific Northwest Multiple Sclerosis (PNWMS) Registry (P3.329)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Reducing Rebound Disease Activity in Relapsing Multiple Sclerosis Patients Electively Transitioned from Natalizumab to Teriflunomide (P2.403)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Use of Medical Marijuana for Symptoms of Multiple Sclerosis (MS) among Participants of the Pacific Northwest MS Registry (PNWMSR) (P7.250)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

Risk of Disease Progression after Starting Dimethyl Fumurate (DMF): Data from the Providence Multiple Sclerosis Center’s DMF Registry. (P3.269)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Characteristics of Persons Unable To Work Due to MS in the Pacific Northwest MS Registry (P03.208)

Neurology, 2013-02, Vol.80 (7_supplement)

2013

Volltextzugriff (PDF)

The Providence Ms Center’s Dimethyl Fumarate (DMF) Registry (P7.236)

Neurology, 2014-04, Vol.82 (10_supplement)

2014

Volltextzugriff (PDF)

The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide

Multiple sclerosis journal - experimental, translational and clinical, 2021-10, Vol.7 (4), p.20552173211066588

2021

Volltextzugriff (PDF)

A Vertically Integrated Project Approach to Ethnographic Methods Training

Teaching Anthropology, 2023-11, Vol.12 (2), p.40-52

2023

Volltextzugriff (PDF)

Results of sustained long-term use of interferon beta-1a in a community-based cohort of patients with relapsing multiple sclerosis

Journal of drug assessment (London, U.K.), 2015-01, Vol.4 (1), p.1-6

2015

Volltextzugriff (PDF)

Countering negative countryoforigin effects

European journal of marketing, 2010-07, Vol.44 (7/8), p.1055-1076

2010

Volltextzugriff (PDF)

Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy

Multiple sclerosis journal - experimental, translational and clinical, 2019-01, Vol.5 (1), p.2055217318824618-2055217318824618

2019

Volltextzugriff (PDF)

Evaluation of a nurse practitioner-led care management model in reducing inpatient drug utilization and cost

Nursing economic, 2009-05, Vol.27 (3), p.160

2009

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(71)
Dissertationen
(1)

Sprache

Englisch
(65)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(29)
Multiple Sclerosis
(9)
Clinical Neurology
(8)
Neurosciences & Neurology
(8)
Humans
(7)
Physical Sciences
(7)
Animals
(6)
Mice
(5)
Oncology
(5)
Radiology And Nuclear Medicine
(5)
Radiology, Nuclear Medicine & Medical Imaging
(5)
Adult
(4)
Agriculture
(4)
Male
(4)
Middle Aged
(4)
Monoclonal Antibodies
(4)
Pharmacology & Pharmacy
(4)
Aged
(3)
Agriculture, Multidisciplinary
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article

Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT)

Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study

Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry

Clinical Trial Awareness in the Black Population from the National African Americans with Multiple Sclerosis Registry (P5-4.007)

Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE)

Evaluating decision regret after extremely preterm birth

Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis

Advancing Care and Outcomes for African American Patients With Multiple Sclerosis

National African American Multiple Sclerosis Registry: Advancing Equitable Care and Outcomes for African Americans with Multiple Sclerosis (4957)

N-Terminomics identifies HtrA1 cleavage of thrombospondin-1 with generation of a proangiogenic fragment in the polarized retinal pigment epithelial cell model of age-related macular degeneration

Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab (OCTAVE) (P3.2-056)

Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center

Comparing Quality of Life Between People Who Use Injectable Disease-Modifying Therapies and Those Who Switch to Oral Therapies: A Study From the Pacific Northwest Multiple Sclerosis (PNWMS) Registry (P3.329)

Reducing Rebound Disease Activity in Relapsing Multiple Sclerosis Patients Electively Transitioned from Natalizumab to Teriflunomide (P2.403)

Use of Medical Marijuana for Symptoms of Multiple Sclerosis (MS) among Participants of the Pacific Northwest MS Registry (PNWMSR) (P7.250)

Risk of Disease Progression after Starting Dimethyl Fumurate (DMF): Data from the Providence Multiple Sclerosis Center’s DMF Registry. (P3.269)

Characteristics of Persons Unable To Work Due to MS in the Pacific Northwest MS Registry (P03.208)

The Providence Ms Center’s Dimethyl Fumarate (DMF) Registry (P7.236)

The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide

A Vertically Integrated Project Approach to Ethnographic Methods Training

Results of sustained long-term use of interferon beta-1a in a community-based cohort of patients with relapsing multiple sclerosis

Countering negative countryoforigin effects

Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy

Evaluation of a nurse practitioner-led care management model in reducing inpatient drug utilization and cost

Suchergebnisse filtern